DENMARK - Vækstfonden invests $ 19.27m in series B round in Egalet
Vækstfonden has invested $19.27m in Egalet, a pharmaceutical company that specialises in oral controlled released products. The investment will be used to expand and optimise its proprietary product portfolio.
More on Expansion
VCs in €12m round for GreenCom Networks
Corporate venture arm Shell Ventures leads the round for the IoT energy systems software platform
Omers leads $20m round for Ultimate.ai
New investor Felicis Ventures also backed the round for the customer service automation software
LDC acquires minority stake in Foundation SP
LDC has backed the company's existing management team, led by Simon Grosse as CEO
Investors in £60m round for Monzo at £1.24bn valuation
Monzo has been using the UK furlough scheme and subsequently making around 80 employees redundant
Latest News
Nazca exits Moldcom to Cranemere's ES Group
This is the first divestment made by Nazca IV, a €275m vehicle raised by the GP in 2016
Hg-backed IT Relation bolts on Improsec
With the latest acquisition, IT Relation will add cybersecurity as its fourth business area, alongside cloud services, business consultancy and professional services
Mutares-backed Balcke-Dürr sells Rothemühle to trade
Industrial energy efficiency equipment producer sold its Poland-based operations in April 2020
Horizon's Timico buys Arcus Cloud Services
Horizon bought a majority stake in Timico in 2016 via a deal valuing the company at more than £50m